WS04.4 Guidance on the use of sputum biomarkers to monitor treatment response and act as trial outcomes in cystic fibrosis

A. Lepissier, C. Addy, D. Downey, K. Hayes, I. Sermet

Research output: Contribution to journal › Meeting abstract › peer-review

Access to Document

Infection, inflammation and biomarkers in Cystic Fibrosis
Addy, C. (Author), Downey, D. (Supervisor), Elborn, S. (Supervisor) & Bradley, J. (Supervisor), Jul 2019
Student thesis: Doctoral Thesis › Doctor of Philosophy

@article{6187c18d190f4436991dc933aca16f18,

title = "WS04.4 Guidance on the use of sputum biomarkers to monitor treatment response and act as trial outcomes in cystic fibrosis",

author = "A. Lepissier and C. Addy and D. Downey and K. Hayes and I. Sermet",

year = "2020",

month = jun,

day = "1",

doi = "10.1016/s1569-1993(20)30186-7",

language = "English",

volume = "19",

pages = "S7",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - WS04.4 Guidance on the use of sputum biomarkers to monitor treatment response and act as trial outcomes in cystic fibrosis

AU - Lepissier, A.

AU - Addy, C.

AU - Downey, D.

AU - Hayes, K.

AU - Sermet, I.

PY - 2020/6/1

Y1 - 2020/6/1

U2 - 10.1016/s1569-1993(20)30186-7

DO - 10.1016/s1569-1993(20)30186-7

M3 - Meeting abstract

SN - 1569-1993

VL - 19

SP - S7

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

ER -